Literature DB >> 7489974

Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.

H Noguchi1, K Hirai, Y Aoki, K Sakata, K Tanikawa.   

Abstract

We performed a partial splenic arterial embolization in 22 patients with cirrhosis associated with thrombocytopenia and then evaluated the changes in platelet kinetics after undergoing the procedure using 111In-tropolone-labeled platelets. The controls consisted of eight chronic hepatitis patients who showed a normal platelet count and normal spleen size. The mean splenic infarction ratio after the procedure was 54.9%. A platelet kinetics study was performed before and 2 months after the procedure. Before the procedure, the cirrhotic patients showed increases in the splenic volume and the spleen/liver uptake ratio of the 111In-labeled platelets on both the third and seventh days, and a decrease in the platelet recovery compared with the controls, which suggested an increased platelet pool in the spleen. In addition, the platelet survival time in cirrhotic patients was shortened, whereas the platelet-associated immunoglobulin G (PA-IgG) was higher than that of the controls, which suggested the involvement of immunologic mechanisms in the thrombocytopenia. With an increase of the platelet count after a partial splenic arterial embolization, the spleen/liver uptake ratio of the 111In-labeled platelets decreased, whereas the platelet recovery increased. Furthermore, the platelet survival time was prolonged, whereas the PA-IgG decreased. The platelet count showed a positive correlation with the platelet survival time and a negative correlation with PA-IgG before and after the procedure. These results suggest that a transcatheter splenic arterial embolization not only may reduce the increased platelet pool in the spleen but also may improve the thrombocytopenia induced by immunologic mechanisms in patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489974

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.

Authors:  Heba M Abdella; Amal T Abd-El-Moez; Mohammed E Abu El-Maaty; Ali Z Helmy
Journal:  Indian J Gastroenterol       Date:  2010-05-05

2.  Significance of laparoscopic splenectomy in patients with hypersplenism.

Authors:  Yuji Watanabe; Atsushi Horiuchi; Motohira Yoshida; Yuji Yamamoto; Hiroki Sugishita; Teru Kumagi; Yoichi Hiasa; Kanji Kawachi
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

Review 3.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

4.  Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.

Authors:  Chi-Ming Lee; Ting-Kai Leung; Hung-Jung Wang; Wei-Hsing Lee; Li-Kuo Shen; Jean-Dean Liu; Chun-Chao Chang; Ya-Yen Chen
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

5.  Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.

Authors:  Mingyue Cai; Wensou Huang; Chaoshuang Lin; Zhengran Li; Jiesheng Qian; Mingsheng Huang; Zhaolin Zeng; Jingjun Huang; Hong Shan; Kangshun Zhu
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

6.  Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option.

Authors:  Guilherme Lopes P Martins; Joao Paulo G Bernardes; Marcello S Rovella; Raphael G Andrade; Publio Cesar C Viana; Paulo Herman; Giovanni Guido Cerri; Marcos Roberto Menezes
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

7.  Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients.

Authors:  Mahmoud A Amin; Mohamed M el-Gendy; Ibrahim E Dawoud; Ashraf Shoma; Ahmed M Negm; Talal A Amer
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

8.  Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

9.  Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.

Authors:  Jin-Hua Huang; Fei Gao; Yang-Kui Gu; Wen-Quan Li; Lian-Wei Lu
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

10.  Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.

Authors:  Tomohiko Akahoshi; Morimasa Tomikawa; Daisuke Korenaga; Koji Ikejiri; Motonori Saku; Kenji Takenaka
Journal:  Surg Endosc       Date:  2009-08-19       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.